Browse
Submit Data
Databases
API
Help

Dataset Information

19 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Guide for Sparse PCA: Model Comparison and Applications.

ABSTRACT: PCA is a popular tool for exploring and summarizing multivariate data, especially those consisting of many variables. PCA, however, is often not simple to interpret, as the components are a linear combination of the variables. To address this issue, numerous methods have been proposed to sparsify the nonzero coefficients in the components, including rotation-thresholding methods and, more recently, PCA methods subject to sparsity inducing penalties or constraints. Here, we offer guidelines on how to choose among the different sparse PCA methods. Current literature misses clear guidance on the properties and performance of the different sparse PCA methods, often relying on the misconception that the equivalence of the formulations for ordinary PCA also holds for sparse PCA. To guide potential users of sparse PCA methods, we first discuss several popular sparse PCA methods in terms of where the sparseness is imposed on the loadings or on the weights, assumed model, and optimization criterion used to impose sparseness. Second, using an extensive simulation study, we assess each of these methods by means of performance measures such as squared relative error, misidentification rate, and percentage of explained variance for several data generating models and conditions for the population model. Finally, two examples using empirical data are considered.

SUBMITTER: Guerra-Urzola R

PROVIDER: S-EPMC8636462 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Sparse non-negative generalized PCA with applications to metabolomics.

Project description:MotivationNuclear magnetic resonance (NMR) spectroscopy has been used to study mixtures of metabolites in biological samples. This technology produces a spectrum for each sample depicting the chemical shifts at which an unknown number of latent metabolites resonate. The interpretation of this data with common multivariate exploratory methods such as principal components analysis (PCA) is limited due to high-dimensionality, non-negativity of the underlying spectra and dependencies at adjacent chemical shifts.ResultsWe develop a novel modification of PCA that is appropriate for analysis of NMR data, entitled Sparse Non-Negative Generalized PCA. This method yields interpretable principal components and loading vectors that select important features and directly account for both the non-negativity of the underlying spectra and dependencies at adjacent chemical shifts. Through the reanalysis of experimental NMR data on five purified neural cell types, we demonstrate the utility of our methods for dimension reduction, pattern recognition, sample exploration and feature selection. Our methods lead to the identification of novel metabolites that reflect the differences between these cell types.Availabilitywww.stat.rice.edu/~gallen/software.html.Contactgallen@rice.edu.Supplementary informationSupplementary data are available at Bioinformatics online.

| S-EPMC3198582 | biostudies-literature

Dynamic Meta-data Network Sparse PCA for Cancer Subtype Biomarker Screening.

Project description:Previous research shows that each type of cancer can be divided into multiple subtypes, which is one of the key reasons that make cancer difficult to cure. Under these circumstances, finding a new target gene of cancer subtypes has great significance on developing new anti-cancer drugs and personalized treatment. Due to the fact that gene expression data sets of cancer are usually high-dimensional and with high noise and have multiple potential subtypes' information, many sparse principal component analysis (sparse PCA) methods have been used to identify cancer subtype biomarkers and subtype clusters. However, the existing sparse PCA methods have not used the known cancer subtype information as prior knowledge, and their results are greatly affected by the quality of the samples. Therefore, we propose the Dynamic Metadata Edge-group Sparse PCA (DM-ESPCA) model, which combines the idea of meta-learning to solve the problem of sample quality and uses the known cancer subtype information as prior knowledge to capture some gene modules with better biological interpretations. The experiment results on the three biological data sets showed that the DM-ESPCA model can find potential target gene probes with richer biological information to the cancer subtypes. Moreover, the results of clustering and machine learning classification models based on the target genes screened by the DM-ESPCA model can be improved by up to 22-23% of accuracies compared with the existing sparse PCA methods. We also proved that the result of the DM-ESPCA model is better than those of the four classic supervised machine learning models in the task of classification of cancer subtypes.

| S-EPMC9197542 | biostudies-literature

Sparse PCA corrects for cell type heterogeneity in epigenome-wide association studies.

Project description:In epigenome-wide association studies (EWAS), different methylation profiles of distinct cell types may lead to false discoveries. We introduce ReFACTor, a method based on principal component analysis (PCA) and designed for the correction of cell type heterogeneity in EWAS. ReFACTor does not require knowledge of cell counts, and it provides improved estimates of cell type composition, resulting in improved power and control for false positives in EWAS. Corresponding software is available at http://www.cs.tau.ac.il/~heran/cozygene/software/refactor.html.

| S-EPMC5548182 | biostudies-literature

A Sparse Mixture-of-Experts Model With Screening of Genetic Associations to Guide Disease Subtyping.

Project description:Motivation: Identifying new genetic associations in non-Mendelian complex diseases is an increasingly difficult challenge. These diseases sometimes appear to have a significant component of heritability requiring explanation, and this missing heritability may be due to the existence of subtypes involving different genetic factors. Taking genetic information into account in clinical trials might potentially have a role in guiding the process of subtyping a complex disease. Most methods dealing with multiple sources of information rely on data transformation, and in disease subtyping, the two main strategies used are 1) the clustering of clinical data followed by posterior genetic analysis and 2) the concomitant clustering of clinical and genetic variables. Both of these strategies have limitations that we propose to address. Contribution: This work proposes an original method for disease subtyping on the basis of both longitudinal clinical variables and high-dimensional genetic markers via a sparse mixture-of-regressions model. The added value of our approach lies in its interpretability in relation to two aspects. First, our model links both clinical and genetic data with regard to their initial nature (i.e., without transformation) and does not require post-processing where the original information is accessed a second time to interpret the subtypes. Second, it can address large-scale problems because of a variable selection step that is used to discard genetic variables that may not be relevant for subtyping. Results: The proposed method was validated on simulations. A dataset from a cohort of Parkinson's disease patients was also analyzed. Several subtypes of the disease and genetic variants that potentially have a role in this typology were identified. Software availability: The R code for the proposed method, named DiSuGen, and a tutorial are available for download (see the references).

| S-EPMC9207464 | biostudies-literature

Quantitative Comparison of Deep Learning-Based Image Reconstruction Methods for Low-Dose and Sparse-Angle CT Applications.

Project description:The reconstruction of computed tomography (CT) images is an active area of research. Following the rise of deep learning methods, many data-driven models have been proposed in recent years. In this work, we present the results of a data challenge that we organized, bringing together algorithm experts from different institutes to jointly work on quantitative evaluation of several data-driven methods on two large, public datasets during a ten day sprint. We focus on two applications of CT, namely, low-dose CT and sparse-angle CT. This enables us to fairly compare different methods using standardized settings. As a general result, we observe that the deep learning-based methods are able to improve the reconstruction quality metrics in both CT applications while the top performing methods show only minor differences in terms of peak signal-to-noise ratio (PSNR) and structural similarity (SSIM). We further discuss a number of other important criteria that should be taken into account when selecting a method, such as the availability of training data, the knowledge of the physical measurement model and the reconstruction speed.

| S-EPMC8321320 | biostudies-literature

Biologically-informed neural networks guide mechanistic modeling from sparse experimental data.

Project description:Biologically-informed neural networks (BINNs), an extension of physics-informed neural networks [1], are introduced and used to discover the underlying dynamics of biological systems from sparse experimental data. In the present work, BINNs are trained in a supervised learning framework to approximate in vitro cell biology assay experiments while respecting a generalized form of the governing reaction-diffusion partial differential equation (PDE). By allowing the diffusion and reaction terms to be multilayer perceptrons (MLPs), the nonlinear forms of these terms can be learned while simultaneously converging to the solution of the governing PDE. Further, the trained MLPs are used to guide the selection of biologically interpretable mechanistic forms of the PDE terms which provides new insights into the biological and physical mechanisms that govern the dynamics of the observed system. The method is evaluated on sparse real-world data from wound healing assays with varying initial cell densities [2].

| S-EPMC7732115 | biostudies-literature

High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics.

Project description:We describe studies in molecular profiling and biological pathway analysis that use sparse latent factor and regression models for microarray gene expression data. We discuss breast cancer applications and key aspects of the modeling and computational methodology. Our case studies aim to investigate and characterize heterogeneity of structure related to specific oncogenic pathways, as well as links between aggregate patterns in gene expression profiles and clinical biomarkers. Based on the metaphor of statistically derived "factors" as representing biological "subpathway" structure, we explore the decomposition of fitted sparse factor models into pathway subcomponents and investigate how these components overlay multiple aspects of known biological activity. Our methodology is based on sparsity modeling of multivariate regression, ANOVA, and latent factor models, as well as a class of models that combines all components. Hierarchical sparsity priors address questions of dimension reduction and multiple comparisons, as well as scalability of the methodology. The models include practically relevant non-Gaussian/nonparametric components for latent structure, underlying often quite complex non-Gaussianity in multivariate expression patterns. Model search and fitting are addressed through stochastic simulation and evolutionary stochastic search methods that are exemplified in the oncogenic pathway studies. Supplementary supporting material provides more details of the applications, as well as examples of the use of freely available software tools for implementing the methodology.

| S-EPMC3017385 | biostudies-literature

LARGE-SCALE MULTIVARIATE SPARSE REGRESSION WITH APPLICATIONS TO UK BIOBANK.

Project description:In high-dimensional regression problems, often a relatively small subset of the features are relevant for predicting the outcome, and methods that impose sparsity on the solution are popular. When multiple correlated outcomes are available (multitask), reduced rank regression is an effective way to borrow strength and capture latent structures that underlie the data. Our proposal is motivated by the UK Biobank population-based cohort study, where we are faced with large-scale, ultrahigh-dimensional features, and have access to a large number of outcomes (phenotypes)-lifestyle measures, biomarkers, and disease outcomes. We are hence led to fit sparse reduced-rank regression models, using computational strategies that allow us to scale to problems of this size. We use a scheme that alternates between solving the sparse regression problem and solving the reduced rank decomposition. For the sparse regression component we propose a scalable iterative algorithm based on adaptive screening that leverages the sparsity assumption and enables us to focus on solving much smaller subproblems. The full solution is reconstructed and tested via an optimality condition to make sure it is a valid solution for the original problem. We further extend the method to cope with practical issues, such as the inclusion of confounding variables and imputation of missing values among the phenotypes. Experiments on both synthetic data and the UK Biobank data demonstrate the effectiveness of the method and the algorithm. We present multiSnpnet package, available at http://github.com/junyangq/multiSnpnet that works on top of PLINK2 files, which we anticipate to be a valuable tool for generating polygenic risk scores from human genetic studies.

| S-EPMC9454085 | biostudies-literature

Variable Selection in Heterogeneous Datasets: A Truncated-rank Sparse Linear Mixed Model with Applications to Genome-wide Association Studies.

Project description:A fundamental and important challenge in modern datasets of ever increasing dimensionality is variable selection, which has taken on renewed interest recently due to the growth of biological and medical datasets with complex, non-i.i.d. structures. Naïvely applying classical variable selection methods such as the Lasso to such datasets may lead to a large number of false discoveries. Motivated by genome-wide association studies in genetics, we study the problem of variable selection for datasets arising from multiple subpopulations, when this underlying population structure is unknown to the researcher. We propose a unified framework for sparse variable selection that adaptively corrects for population structure via a low-rank linear mixed model. Most importantly, the proposed method does not require prior knowledge of individual relationships in the data and adaptively selects a covariance structure of the correct complexity. Through extensive experiments, we illustrate the effectiveness of this framework over existing methods. Further, we test our method on three different genomic datasets from plants, mice, and humans, and discuss the knowledge we discover with our model.

| S-EPMC5889139 | biostudies-literature

PCA via joint graph Laplacian and sparse constraint: Identification of differentially expressed genes and sample clustering on gene expression data.

Project description:BACKGROUND:In recent years, identification of differentially expressed genes and sample clustering have become hot topics in bioinformatics. Principal Component Analysis (PCA) is a widely used method in gene expression data. However, it has two limitations: first, the geometric structure hidden in data, e.g., pair-wise distance between data points, have not been explored. This information can facilitate sample clustering; second, the Principal Components (PCs) determined by PCA are dense, leading to hard interpretation. However, only a few of genes are related to the cancer. It is of great significance for the early diagnosis and treatment of cancer to identify a handful of the differentially expressed genes and find new cancer biomarkers. RESULTS:In this study, a new method gLSPCA is proposed to integrate both graph Laplacian and sparse constraint into PCA. gLSPCA on the one hand improves the clustering accuracy by exploring the internal geometric structure of the data, on the other hand identifies differentially expressed genes by imposing a sparsity constraint on the PCs. CONCLUSIONS:Experiments of gLSPCA and its comparison with existing methods, including Z-SPCA, GPower, PathSPCA, SPCArt, gLPCA, are performed on real datasets of both pancreatic cancer (PAAD) and head & neck squamous carcinoma (HNSC). The results demonstrate that gLSPCA is effective in identifying differentially expressed genes and sample clustering. In addition, the applications of gLSPCA on these datasets provide several new clues for the exploration of causative factors of PAAD and HNSC.

| S-EPMC6936054 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data